Why is "Alopecia areata" trending?

Search Interest Perspective

• Drugmaker Seeks Alopecia Areata Indication for Upadacitinib - Medscape
• Upadacitinib sNDA Submitted to FDA for Severe Alopecia Areata - HCPLive
• AbbVie seeks FDA approval for upadacitinib in severe alopecia areata - Contemporary Pediatrics
• Deuruxolitinib Demonstrates Consistent Efficacy, Early Hair Regrowth in Severe Alopecia Areata - The American Journal of Managed Care
• AbbVie files Rinvoq for alopecia areata with Phase III win - The Pharma Letter
• ABBV Seeks FDA Nod for Rinvoq Label Expansion in Alopecia Areata - Yahoo Finance
• Hair-loss drug bid: AbbVie asks FDA to expand RINVOQ use - Stock Titan
• Dental Rehabilitation of a Child Diagnosed With Alopecia Areata Totalis: A Case Report - Cureus
• FDA filing for investigational alopecia areata treatment lifts AbbVie stock 3.65% - Traders Union
• Alopecia areata - Nature
• Risk for alopecia areata development in atopic dermatitis falls after starting dupilumab - Healio
• Deuruxolitinib Is Beneficial for Scalp Hair Regrowth in Alopecia Areata - Dermatology Advisor
• What is alopecia areata? - UCLA Health
• MHRA approves new treatment for severe alopecia areata - PharmaTimes
• Topical Immunotherapy Remains Valuable in Alopecia Areata - The American Journal of Managed Care
• Alopecia Areata in a Patient Undergoing Treatment for Secondary Syphilis: A Diagnostic Challenge - Cureus
• First in Class Rezpegaldesleukin: Favorable Safety, Durable Responses in Alopecia Areata, With David Rosmarin, MD - HCPLive
• Hematological ratios in pediatric patients with alopecia areata based on a nationwide retrospective cohort study - Nature
• Alopecia Areata Market Set to Expand by 2036, Due to the Emergence of Novel Drug Classes Such as OX40L Inhibitors, IL-2 Inhibitors, IL-7Rα, and Others | DelveInsight - Yahoo Finance
• Applying Clinical Trial Data to Alopecia Areata Treatment - Dermatology Times
• Early prediction of alopecia areata using machine learning modeling of neuro stress immune signatures from multi datasets - Nature
• Biggest Misconceptions Derms Hear About Alopecia Areata - HealthCentral
• Alopecia Areata Possibly Secondary to COVID-19 Vaccine - Consultant360
• Rethinking Severity Assessment in Alopecia Areata - Dermatology Times
• Significant improvement with ivarmacitinib after suboptimal response to tofacitinib in severe alopecia areata: a case report and literature review - Frontiers
• AAD 2026: Strong Week 24 Outcomes in Severe Alopecia Areata - EMJ
• TH1 effector CD4 T cells rely on IFN-γ production to induce alopecia areata - Science | AAAS
• From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology - Frontiers
• Case Report: Alopecia areata in an adolescent after COVID-19 infection - Frontiers
• Alopecia Areata May Raise Risk for Autoimmune Diseases - Medscape
• Moderate to Severe Alopecia Areata Linked to Higher Risk of Atopic Dermatitis Diagnosis - The American Journal of Managed Care
• New Alopecia Areata Treatments Are Helping People Regrow Hair — and Hope - Everyday Health
• Sun Pharma Highlights Advances in Alopecia Areata, Psoriasis, and Acne Research at 2026 AAD Annual Meeting - PR Newswire
• What Works for Patients with Alopecia Areata - Dermatology Times
• Surveys Show Differences in Patient, Clinician Perspectives on the Impact of Alopecia Areata - The American Journal of Managed Care
• REZOLVE-AA Phase 2b Study of Rezpegaldesleukin Establishes Proof-of-Concept in Patients with Severe-to-Very-Severe Alopecia Areata - PR Newswire
• Alcohol's Impact on Alopecia Areata: Harmful or Protective? - Everyday Health
• Dual ITK/JAK3 Inhibition Shows Strong Preclinical Activity in Severe Alopecia Areata - Dermatology Times
• Challenges and Treatments in Alopecia Areata - HMP Global Learning Network
• Systemic Inflammation Linked to Disease Severity, Treatment Response in Alopecia Areata - The American Journal of Managed Care
• Upadacitinib Shows Strong Efficacy in Second Pivotal Phase 3 Study for Severe Alopecia Areata - Dermatology Times
• 10 Self-Care Tips for Managing Alopecia Areata - HealthCentral
• Long-Term Treatment with Ritlecitinib for Alopecia Areata, With Brett King, MD, PhD - HCPLive
• A meta-analysis of chemokines in alopecia areata: recruiting immune cells toward the hair follicle - Frontiers
• ‌Global burden of alopecia areata from 1990 to 2019 and emerging treatment trends analyzed through GBD 2019 and bibliometric data - Nature
• Systemic, Not Just Local, Inflammation Implicated as a Driver of Alopecia Areata - Medscape
• Hair for the Long Haul: Alopecia Areata Cases and Considerations - EMJ
• How to Talk to Your Dermatologist About Treatment-Resistant Alopecia Areata - Everyday Health
• Nektar says potential Dupixent challenger finds a foothold in alopecia areata - FirstWord Pharma
• MHRA approves Leqselvi for severe alopecia areata - PMLiVE
• Alopecia Areata Linked to Adverse Pregnancy Outcomes - Medscape
• Adherence to Alopecia Areata Therapies - The American Journal of Managed Care
• Diagnosis of Alopecia Areata - The American Journal of Managed Care
• MHRA approves deuruxolitinib (Leqselvi) to treat severe alopecia areata in adults - GOV.UK
• Noteworthy Studies on JAK Inhibitors, Skin-Gut Relationship in Alopecia Areata: Maria Hordinsky, MD - The American Journal of Managed Care
• Nektar Therapeutics announces top-line results from alopecia areata study - PMLiVE
• Young Adults Face Highest Burden of Alopecia Areata, Global Study Finds - The American Journal of Managed Care
• Nektar to Hold Conference Call to Discuss 52-Week Topline Results from the 16-Week Extension Treatment Period for its REZOLVE-AA Phase 2b Study of Rezpegaldesleukin in Alopecia Areata on April 20, 2026 - Yahoo Finance
• Utilizing CYP2C9 Testing and JAK Inhibitors for Alopecia Areata - Dermatology Times
• AbbVie’s upadacitinib raises the bar for alopecia areata - Clinical Trials Arena
• Alopecia Areata: Coping With Anxiety and Depression - Everyday Health
• Visibility, Not Lesion Burden, Drives Distress in Alopecia Areata - The American Journal of Managed Care
• Managing Alopecia Areata With JAK Inhibitors: Timing, Response, and Long-Term Strategy - HMP Global Learning Network
• How Can Alopecia Areata Cause Nail Changes? - HealthCentral
• Baricitinib demonstrates sustained hair regrowth in adolescents with alopecia areata - Contemporary Pediatrics
• Hallmark Symptoms Seen With Alopecia Areata - The American Journal of Managed Care
• Case-Based Insights Highlight Oral JAK Inhibitors for Alopecia Areata - Dermatology Times
• Ritlecitinib Shows Significant Reduction in Alopecia Areata Psychosocial Burden - The American Journal of Managed Care
• Full Scalp Hair Regrowth Possible With Oral JAK Inhibitor - Medscape
• Baricitinib Leads to Significant Hair Regrowth in Adolescents With Severe Alopecia Areata - The American Journal of Managed Care
• Large Language Model Shows Promise for Automating SALT Scoring in Pediatric Alopecia Areata - The American Journal of Managed Care
• Lilly's baricitinib delivered near-complete scalp hair regrowth at one year for adolescents with severe alopecia areata in Phase 3 BRAVE-AA-PEDS trial | Eli Lilly and Company - investor.lilly.com
• Psychosocial Impact of Alopecia Areata in Pediatric Populations - HMP Global Learning Network
• Baricitinib Shows Real-World Effectiveness in Severe Alopecia Areata Hair Loss - The American Journal of Managed Care
• Deuruxolitinib Launches in US for Treatment of Severe Alopecia Areata - Dermatology Times
• 8 Alopecia Innovations You Need to Know About - HealthCentral
• Alopecia Areata Tied to Microscopic Colitis - Medscape
• Strategies for Differentiating Hair Loss Disorders from Alopecia Areata - HCPLive
• Alopecia areata triggered by immune response - UCLA Health
• Early Phototherapy Offers Meaningful Benefit for Certain Patients With Alopecia Areata - The American Journal of Managed Care
• ALOPECIA AREATA AWARENESS MONTH - National Day Calendar
• How to Care for Your Hair and Scalp When You Have Alopecia Areata - Everyday Health
• Top 5 Alopecia Areata Stories DERM 2025 NP/PA Conference - HCPLive
• Alopecia Areata Diet: Best Foods for Hair and Immune Health - HealthCentral
• ALLEGRO 3-Year Data Demonstrate Effectiveness in Alopecia Areata for Adults, Adolescents - HCPLive
• How Alopecia Areata Can Affect Your Mental Health - Cleveland Clinic Health Essentials
• Jonathan Zalevsky, PhD, on Rezpegaldesleukin’s Biologic Approach to Alopecia Areata - Dermatology Times
• Upadacitinib Improves Scalp Hair Coverage for Patients With Severe Alopecia Areata - Drug Topics
• Selective JAK Inhibition With Deuruxolitinib Restores Hair Growth in Alopecia Areata - Dermatology Times
• Top 5 Most-Read Alopecia Content of 2025 - The American Journal of Managed Care
• Brandi's story of Alopecia Areata: How she developed a new sense of identity - WTVC
• Ritlecitinib Spurs Hair Regrowth in Alopecia Areata - The American Journal of Managed Care
• Patient-Reported Hair Satisfaction with Deuruxolitinib for Severe Alopecia Areata - HCPLive
• Tofacitinib in alopecia areata and nephrotic syndrome - Anales de Pediatría
• 5 Things to Know About Alopecia in Children - Everyday Health
• Upadacitinib Shows Strong Efficacy in Phase 3 Alopecia Areata Trial - The American Journal of Managed Care
• Alopecia Areata Linked to Mental Health Crisis - Medscape
• For AA, If One JAK Inhibitor Doesn’t Work, ‘Try, Try Again’ - Medscape
• Lilly's baricitinib exhibits paediatric potential in major alopecia areata study - European Pharmaceutical Review
• AbbVie seeks Rinvoq alopecia approval after second Phase III success - Clinical Trials Arena